Romania's pharmaceutical market grew in value by 15.4% year-on-year in the first half of 2010, to reach a total of 4.88 billion lei ($1.5 billion), according to data from IMS Health, reported by Romanian economic news provider Money.ro.
In euro terms, the increase was 17.6% to 1.17 billion euro ($1.5 billion). The main driver of growth in the sector was prescription drugs, sales of which increased 17.4% to 4.33 billion lei, while hospital drugs showed a contrasting trend, with a fall in sales by value of 5%, to 519 million lei. Sales of over-the-counter (OTC) drugs edged up during the period by 1.3% to 545.3 million.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
| Headless Content Management with Blaze